CorVel Co. (NASDAQ:CRVL) Director Steven J. Hamerslag sold 3,800 shares of the business’s stock in a transaction on Tuesday, June 8th. The stock was sold at an average price of $120.88, for a total transaction of $459,344.00. Following the completion of the sale, the director now directly owns 120,548 shares of the company’s stock, valued at approximately $14,571,842.24. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Shares of NASDAQ CRVL opened at $122.31 on Friday. The stock has a market cap of $2.19 billion, a price-to-earnings ratio of 47.96 and a beta of 1.00. The business has a fifty day moving average of $116.22. CorVel Co. has a one year low of $62.31 and a one year high of $126.90.
CorVel (NASDAQ:CRVL) last announced its earnings results on Thursday, May 27th. The business services provider reported $0.81 earnings per share (EPS) for the quarter. The company had revenue of $145.51 million for the quarter. CorVel had a net margin of 8.39% and a return on equity of 22.32%.
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
Read More: History of the Euro STOXX 50 Index
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.